Delivery Order SPE2DB20D9354-SPE2DB24FX7Q7
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $9,284.40, is a delivery order for XOLAIR 150 MG/ML SYRINGEML, a specialized pharmaceutical product. The contract has a completion date of April 25, 2025 and is a firm fixed-price contract. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,547.40 firm fixed-price delivery order is for the supply of XOLAIR 150 MG/ML SYRINGEML, a specialized pharmaceutical product, with an ultimate completion date of October 10, 2024. The contract is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product XOLAIR 150 MG/ML SYRINGE. The contract has a potential value of $14,700.32 and a completion date of March 1, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that supplies a wide range of branded and generic pharmaceuticals to U.S. government agencies,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $9,284.40, is a firm fixed-price delivery order for the supply of XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) on July 10, 2024 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $18,568.80 firm fixed-price delivery order is for the supply of XOLAIR 150 MG/ML syringes, with a contract period of performance through July 31, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,642.20, is for the supply of XOLAIR 150 MG/ML SYRINGEML, a specialized medication. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue firm fixed-price...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $38,685.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of XOLAIR 150 mg/mL syringes to support the medical needs of defense agencies. DMS Pharmaceutical Group holds a larger indefinite delivery contract with DLA valued up to $4,999,999 through 2025, which enables the agency to issue delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,547.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product, with a completion date of March 5, 2024. This award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which allows the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $106,770.60 contract is for the delivery of XOLAIR 150 MG/ML SYRINGE to be completed by March 25, 2024. This delivery order is placed against DMS Pharmaceutical Group's larger indefinite delivery contract 4600082013 with DLA, valued at up to $4,999,999 through 2025, which enables DLA to order a broad range...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,642.20 contract is for the delivery of XOLAIR 150 MG/ML SYRINGEML, a specialized pharmaceutical product, with a period of performance through May 23, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds...
- SPE2DB20D9354Indefinite Delivery Contract
- SPE2DB20D9354-SPE2DB24FX7Q7Delivery Order
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,642.20, was awarded by the Defense Logistics Agency (DLA) on April 22, 2024, and has a completion date of May 13, 2024. The contract is a delivery order for the item "XOLAIR 150 MG/ML SYRINGEML" and is a Firm Fixed Price contract. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group provides a vast array of medications, including both common and specialized pharmaceutical products, to support the diverse medical needs of military personnel and their dependents across various Department of Defense (DoD) healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 4/22/24 |